Literature DB >> 16824062

Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas.

Tadahiko Masaki1, Hiroyoshi Matsuoka, Masanori Sugiyama, Nobutsugu Abe, Atsuhiko Sakamoto, Yutaka Atomi.   

Abstract

BACKGROUND AND AIM: Treatment of T1 colorectal carcinomas, either local excision including endoscopic polypectomy or radical surgery, has always been problematic in everyday practice. Although previous studies have revealed that tumor budding at the invasive margin can be a marker for the malignant potential of T1 colorectal carcinomas, the evaluation of tumor budding has not been standardized as yet. In the present study, we attempted to apply the actual number of tumor budding units for the individualization of treatment in T1 colorectal carcinomas.
METHODS: In 76 T1 colorectal carcinomas, associations between lymph node metastasis and clinicopathological parameters were examined statistically. A mathematical formula for predicting the risk of lymph node metastasis was constructed and decision analysis was attempted to determine individually the indication for additional surgery after endoscopic mucosal resection of T1 colorectal carcinomas.
RESULTS: Of the clinicopathological parameters examined, multivariate analysis showed that the actual number of tumor budding units alone was significantly associated with lymph node metastasis. The probability of lymph node metastasis was calculated as Z = 0.07 x (budding counts) - 3.726, probability = 1/1 + e(-Z). The more the budding counts, the higher the probability of lymph node metastasis. This formula was able to accurately predict lymph node metastasis in successive cases. The actual number of tumor budding units can be applied to decision analysis in determining an indication for additional surgery after endoscopic mucosal resection of T1 colorectal carcinomas.
CONCLUSIONS: The actual number of tumor budding units may be useful in the decision making for patient-oriented treatment of T1 colorectal carcinomas.

Entities:  

Mesh:

Year:  2006        PMID: 16824062     DOI: 10.1111/j.1440-1746.2006.04073.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

1.  Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy.

Authors:  Marianne Huebner; Bruce G Wolff; Thomas C Smyrk; Jeremiah Aakre; David W Larson
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

2.  Long-Term Outcomes of Endoscopic Versus Surgical Resection of Superficial Submucosal Colorectal Cancer.

Authors:  Ji-Beom Kim; Ho Su Lee; Hyo Jeong Lee; Jihun Kim; Dong-Hoon Yang; Chang Sik Yu; Jin Cheon Kim; Jeong-Sik Byeon
Journal:  Dig Dis Sci       Date:  2015-01-14       Impact factor: 3.199

3.  Transanal endoscopic microsurgery for T1 rectal cancer: size matters!

Authors:  Pascal G Doornebosch; Eliane Zeestraten; Eelco J R de Graaf; Pleun Hermsen; Imro Dawson; Rob A E M Tollenaar; Hans Morreau
Journal:  Surg Endosc       Date:  2011-10-13       Impact factor: 4.584

Review 4.  Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases.

Authors:  Sean C Glasgow; Joshua I S Bleier; Lawrence J Burgart; Charles O Finne; Ann C Lowry
Journal:  J Gastrointest Surg       Date:  2012-01-19       Impact factor: 3.452

Review 5.  Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations.

Authors:  Phil Quirke; Mauro Risio; René Lambert; Lawrence von Karsa; Michael Vieth
Journal:  Virchows Arch       Date:  2011-01       Impact factor: 4.064

Review 6.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Oncotarget       Date:  2010-11

7.  Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.

Authors:  Michael S Landau; Steven M Hastings; Tyler J Foxwell; James D Luketich; Katie S Nason; Jon M Davison
Journal:  Mod Pathol       Date:  2014-04-25       Impact factor: 7.842

Review 8.  Newly recognized extratumoral features of colorectal cancer challenge the current tumor-node-metastasis staging system.

Authors:  Elias Athanasakis; Sofia Xenaki; Maria Venianaki; George Chalkiadakis; Emmanuel Chrysos
Journal:  Ann Gastroenterol       Date:  2018-06-19

9.  Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients.

Authors:  Inti Zlobec; Markus Borner; Alessandro Lugli; Daniel Inderbitzin
Journal:  Int J Surg Oncol       Date:  2012-07-31

10.  Clinical practice guideline for endoscopic resection of early gastrointestinal cancer.

Authors:  Chan Hyuk Park; Dong-Hoon Yang; Jong Wook Kim; Jie-Hyun Kim; Ji Hyun Kim; Yang Won Min; Si Hyung Lee; Jung Ho Bae; Hyunsoo Chung; Kee Don Choi; Jun Chul Park; Hyuk Lee; Min-Seob Kwak; Bun Kim; Hyun Jung Lee; Hye Seung Lee; Miyoung Choi; Dong-Ah Park; Jong Yeul Lee; Jeong-Sik Byeon; Chan Guk Park; Joo Young Cho; Soo Teik Lee; Hoon Jai Chun
Journal:  Intest Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.